Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 11, 2019 - Issue
Submit an article Journal homepage
93
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US

Murtuza Bharmal1 Global Evidence and Value Development, Merck Healthcare KGaA, Darmstadt, GermanyCorrespondence[email protected]
,
Mairead Kearney1 Global Evidence and Value Development, Merck Healthcare KGaA, Darmstadt, Germany
,
Ying Zheng2 US Health Economics and Outcomes Research, EMD Serono, Inc, Rockland, MA, USA
&
Hemant Phatak2 US Health Economics and Outcomes Research, EMD Serono, Inc, Rockland, MA, USA
Pages 349-359 | Published online: 22 May 2019

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.